United States
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 22.23 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
2 |
USD 9.62 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
3 |
USD 4.17 B
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
4 |
USD 3.94 B
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
5 |
USD 2.23 B
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
6 |
USD 1.60 B
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
7 |
USD 1.58 B
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
8 |
USD 1.29 B
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
9 |
USD 962.50 M
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
10 |
USD 565.26 M
|
Sept. 30, 2024 | USD 39.22 | 1.63% |
|
United States |
|
11 |
USD 339.40 M
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
12 |
USD 250.96 M
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
13 |
USD 206.59 M
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
14 |
USD 146.03 M
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
15 |
USD 111.00 M
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
16 |
USD 65.08 M
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
17 |
USD 51.35 M
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
18 |
USD 50.91 M
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
|
19 |
USD 48.35 M
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
20 |
USD 36.21 M
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
21 |
USD 13.68 M
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
22 |
USD 7.29 M
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
23 |
USD 3.63 M
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
24 |
USD 2.15 M
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
|
25 |
USD -1.61 M
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
26 |
USD -3.84 M
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
27 |
USD -5.71 M
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
28 |
USD -7.39 M
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
|
29 |
USD -10.54 M
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
|
30 |
USD -107.26 M
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
31 |
USD -277.10 M
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
32 |
USD -338.00 M
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
33 |
USD -13.97 B
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest EBIT is Johnson & Johnson (NYSE: JNJ) at USD 22.23 B.
The Drugstores & Retail Pharmacies company in United States with the lowest EBIT is Walgreens Boots Alliance, Inc. (NasdaqGS: WBA) at USD -13.97 B.
The top 10 Drugstores & Retail Pharmacies companies in United States by EBIT are Johnson & Johnson, CVS Health Corporation, McKesson Corporation, The Kroger Co., Cencora, Albertsons Companies, Inc., Ulta Beauty, Inc., Bath & Body Works, Inc., Lennox International Inc. and National Retail Properties, Inc..
The bottom 10 Drugstores & Retail Pharmacies companies in United States by EBIT are Walgreens Boots Alliance, Inc., Icahn Enterprises L.P., Viatris Inc., Omnicell, Inc., Biofrontera Inc., Pilulka Lékárny a.s., Aytu BioPharma, Inc., ShotSpotter, Inc., PetMed Express, Inc. and Xponential Fitness, Inc..